MPAM
JNCE

Monarch Partners Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Monarch Partners Asset Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-228,370
Closed -$534K – 162
2022
Q3 		$534K Buy
+228,370
New +$534K 0.16% 131